2DRx SOP - LloydsPharmacy

Associated Risks
The picking process is where drugs are selected from the shelf or FAMA drawer. Picking
should be the first step in the process to allow the correct claim at AMPP (Actual Medicinal
Product Pack) level to be sent to the HSW. The prescription should be read when picking
the prescribed items, not the labels. This should limit the perpetuation of any errors made
during the labelling process. Under no circumstances should any items be assembled at this
stage, it is against GPhC guidelines and may lead to dispensing errors.
After selecting a prescription from the electronic prescription queue it is essential to check
the correct patient has been selected. If the incorrect patient is selected their record will
automatically be populated with the information received on the electronic prescription, for
example date of birth and NHS number. If the patient does not exist on CoMPaSS a new
record should be created.
The customer’s name and address details should be double checked to ensure that the
correct customer’s details are being accessed. If there has been a change in the patient’s
address this should be checked with patient or their representative and if this is confirmed it
is possible to override the electronic data.
After selecting the correct patient if there are any amendments made by the GP they should
be reviewed. It is important any changes to the prescription are brought to the attention of
the pharmacist who will then use their professional judgement as to the best course of
action.
It is essential to compare the information on the paper prescription with the electronic
form to ensure there are no differences. Any differences should be brought to the
attention of the pharmacist.
If there are any changes in the dose, strength or pharmaceutical form since the last
dispensing these should be brought to the attention of the pharmacist undertaking the
pharmaceutical assessment.
Dosage instructions should be changed into CoMPaSS format because there are no standard
coding arrangements for labelling by the GP practices. In addition, the GP’s instructions may
not meet good practice RPS guidelines on labelling.
If the labelling system warns of an interaction, this must be brought to the attention of the
pharmacist undertaking the pharmaceutical assessment.
The label must contain the relevant BNF warnings. Do not rely on the computer system to
do this for you.
If working alone a short ‘mental break’ should be taken between generating a label for the
prescription and the assembly of the relevant prescribed items.
2DRx Standard Operation Procedure July 2011 Page 26